NVAX Q1 2018 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+69.9% YoY

Gross Profit

$10M100.0% margin

Operating Income

-$44M-450.8% margin

Net Income

-$46M-480.2% margin

EPS (Diluted)

$-2.75

QoQ Revenue Growth

-7.3%

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$66M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$276M

Total Liabilities

$375M

Stockholders' Equity

-$99M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$6M	+69.9%
Gross Profit	$10M	$6M	+69.9%
Operating Income	-$44M	-$41M	-6.6%
Net Income	-$46M	-$44M	-5.7%